Characteristics of Adult T-Cell Leukemia/Lymphoma Patients with Long Survival: Prognostic Significance of Skin Lesions and Possible Beneficial Role of Valproic Acid

Table 2

Clinical and biological characteristics of Adult T-cell Leukemia/Lymphoma (ATL) patients, diagnosed between 1st January 1983 and 31st March 2013, presenting with a survival superior to 10 years (long survival) in Martinique.

Patient

Age (years)

Gende

ATL typ

AD

S

H

C

S

H

P

Pl

Ly

AbN ly (%)

C

LD

Eo

1

46

F

chr

+

−

−

−

+

11.7

3,1

192.0

10,1

58.0

−

1.0

−

2

40

F

chr

−

−

−

+

−

13.6

10,9

254.0

174,0

89.0

−

1.0

+

3

46

F

chr

−

−

−

+

−

7.3

4.3

NK

4,1

NK

−

2.1

−

4

50

M

lym

+

−

−

+

+

13.0

6.0

230.0

1,5

0.0

−

1.9

+

5

34

M

lym

+

−

−

−

−

9.7

0.9

127.0

1,5

0.0

+

2.6

−

6

62

F

lym

−

−

+

+

−

7.8

1.0

232.0

3,7

0.0

−

4.6

+

7

16

F

chr

−

−

−

+

−

11.5

2.0

N

3,6

9.0

−

1.0

−

8

36

M

lym

+

−

−

+

−

12.1

4,5

153.0

1,7

0.0

+

4.1

−

9

68

M

chr

+

−

−

+

+

12.9

3.6

154.0

2.4

33.0

−

1.1

+

10

45

F

lym

+

−

−

+

−

N

N

N

N

0.0

−

1.0

−

M: male, F: female, chr:chronic – lym: lymphoma,ADP: adenomegaly, SM: splenomegaly, HM: hepatomegaly, CL: cutaneous lesions, Ss: Strongyloides stercoralis, and Hb: hemoglobin (g/dL).
PN: polynuclear cells (1 × 10⁹/L), Plt: platelet (1 × 10⁹/L), Lym: lymphocytes (1 × 10⁹/L), AbN lymph: abnormal lymphocytes (% of atypical lymphocytes relative to total lymphocytes), Ca: hypercalcemia, LDH: lactate dehydrogenase (expressed as multiples of the normal value), Eos: eosinophilia (1 × 10⁹/L), +: presence, −: absence, N: within normal range, and NK: not known.